- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03690219
Prevalence of Acute Injuries in Amateur and Elite Mountain Bikers
September 25, 2025 updated by: University of Applied Sciences and Arts of Southern Switzerland
The investigators intented to assess the prevalence of acute injuries in amateur and elite mountain bikers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In order to assess the prevalence of acute injuries in amateur and elite mountain bikers a questionnaire was created in accordance to existing literature.
The questionnaire was translated in several languages by bilingual people familiar with mountain biking.
The questionnaire focussed on demographic data, training volume, number of races per year, number of injuries since practising mountain biking, wearing of protective gear items and accident mechanism.
The survey was conducted during the Swiss Epic Mountain Bike Event in 2017.
All riders were asked to voluntarily participate in the survey.
Study Type
Observational
Enrollment (Actual)
99
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kanton Graubünden
-
Landquart, Kanton Graubünden, Switzerland, CH-7302
- SUPSI
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
The investigators included all mountain bikers participating in the Swiss Epic Mountain Bike Event in 2017, who agreed to attend in the survey.
Description
Inclusion Criteria:
- mountain bikers participating in the Swiss Epic Mountain Bike Event in 2017
Exclusion Criteria:
- non-participators, non-mountain bikers in the Swiss Epic Mountain Bike Event in 2017
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prevalence of Injuries in Amateur and Elite Mountain Bikers
Time Frame: At study enrollment, based on participants' self-reported history of mountain bike injuries
|
In a retrospective questionnaire participants were asked about the "Number of injuries obtained during mountain biking".
|
At study enrollment, based on participants' self-reported history of mountain bike injuries
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Training and Racing Volume
Time Frame: At study enrollment, based on participants' retrospective self-report of the number of races per year and estimated training hours per week
|
In a retrospective questionnaire the participants were asked "How many races per year" they ride and whats their "Estimated training hours per week in regard to the season". The number of races per year was multiplied by the factor 4 to transform the number of races into training hours. Then, both values were added to get the training volume per year. |
At study enrollment, based on participants' retrospective self-report of the number of races per year and estimated training hours per week
|
|
Years Practising Mountain Biking
Time Frame: At study enrollment, based on participants' self-reported history of mountain bike participation
|
In a retrospective questionnaire participants were asked "Since how many years do you participate in mountain biking?".
|
At study enrollment, based on participants' self-reported history of mountain bike participation
|
|
Amount of Protective Gear Items
Time Frame: At study enrollment, based on participants' retrospective self-report of protective gear use
|
In a retrospective questionnaire participants were asked to tick the protective gear (helment, gloves, eveywear, upper armour, lower armout, other) they are using for mountain biking.
|
At study enrollment, based on participants' retrospective self-report of protective gear use
|
|
Injury Rate Per 1000hrs Exposure Time
Time Frame: At study enrollment, based on participants' self-reported history of mountain bike participation
|
The injury rate per 1000 hours exposure time was calculated as follows: the hours of exposure time per year were multiplied by the number of years practicing mountain biking to get the total hours at risk.
Then, the total amount of injuries ever was divided by the total hours at risk, multiplied by 1000 hours to get the injury rate per 1000 hours of exposure time.
|
At study enrollment, based on participants' self-reported history of mountain bike participation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ron Clijsen, PhD, University of Applied Sciences and Arts of Southern Switzerland SUPSI
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 11, 2017
Primary Completion (Actual)
September 16, 2017
Study Completion (Actual)
September 16, 2017
Study Registration Dates
First Submitted
September 12, 2018
First Submitted That Met QC Criteria
September 27, 2018
First Posted (Actual)
October 1, 2018
Study Record Updates
Last Update Posted (Actual)
October 20, 2025
Last Update Submitted That Met QC Criteria
September 25, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MTB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Injury in Mountain Biking
-
United States Army Research Institute of Environmental...Walter Reed Army Institute of Research (WRAIR); University of Reading; US Army...CompletedAcute Mountain Sickness | Gastrointestinal InjuryUnited States
-
China Medical University HospitalChina Medical University, ChinaUnknownAcute Mountain Sickness (AMS)Taiwan
-
University of UtahCompletedProphylaxis of Acute Mountain SicknessUnited States
-
Tasly Pharmaceuticals, Inc.CompletedAcute Mountain Sickness (AMS)United States, China
-
Tasly Pharmaceuticals, Inc.CompletedAcute Mountain Sickness (AMS)United States
-
Robert J Noveck, M.D.United States Department of DefenseCompletedAcute Mountain Sickness and FatigueUnited States
-
Sanliurfa Mehmet Akif Inan Education and Research...CompletedIn Acute Kidney InjuryTurkey (Türkiye)
-
Mountain Medicine Society of NepalCompletedAcute Mountain Sickness, Blood Oxygen Saturation, HeadacheNepal
-
Peking University First HospitalTibet Autonomous Region Hospital of Traditional Tibetan MedicineNot yet recruiting
-
University of OregonCompleted
Clinical Trials on no intervention
-
Hopital FochNot yet recruitingInterstitial Lung DiseaseFrance
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Huashan HospitalZhejiang Cancer Hospital; Shanghai Zhongshan Hospital; Tongji Hospital; Qilu Hospital... and other collaboratorsRecruitingHead and Neck Squamous Cell Carcinoma | Patient Derived Organoid | Drug Sensitive Test in VitroChina
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown